Headline
The latest stories from AHA Today.
The Department of Health and Human Services yesterday released a fact sheet summarizing federal efforts to address Long COVID — the signs, symptoms and conditions that can continue or develop after initial COVID-19 or SARS-CoV-2 infection.
The Food and Drug Administration today withdrew approval for Makena and its generics, citing a confirmatory study that did not verify clinical benefit. Makena had been approved under the FDA’s accelerated approval pathway to reduce the risk of preterm birth in women pregnant with one baby who have…
Discover how the ASAP 340B coalition's policy proposals contradict Congress' intent to preserve the 340B program. Patients' lives are at stake.
AHA President and CEO Rick Pollack introduces this special podcast, the story of how one man is working to change the world by delivering refurbished ambulances for second service in Ukraine.
As the COVID-19 public health emergency’s continuous coverage requirement ends and states redetermine eligibility for Medicaid and Children’s Health Insurance Program enrollees, the Department of Health and Human Services’ Office for Civil Rights yesterday reminded state health officials of their…
The Centers for Medicare & Medicaid Services April 5 released a final rule that would increase oversight of Medicare Advantage plans and better align them with Traditional Medicare, address access gaps in behavioral health services and further streamline prior authorization processes.
The Centers for Medicare & Medicaid Services April 4 issued a proposed rule for the inpatient psychiatric facility prospective payment system for fiscal year 2024.
The Department of Health and Human Services April 3 released a national plan to advance the fight against cancer, which includes strategies to prevent cancer, detect cancers early, develop effective treatments, eliminate inequities, engage people in cancer research, deliver optimal care, maximize…
The ABIM Foundation and the Beryl Institute are surveying clinicians to learn more about best practices and ideas for health care organizations and leaders building trust with physicians, nurses, physician assistants and other practitioners.
The Food and Drug Administration April 3 announced that it will require manufacturers of opioid analgesics used in outpatient settings to modify their Risk Evaluation and Mitigation Strategy within 180 days to make prepaid mail-back envelopes and educational materials on safe opioid disposal…